These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 9182364)

  • 21. [Is it time for revision of the section on obsessive-compulsive disorder in the Guideline on Anxiety Disorders?].
    van Ingen Schenau WJ; Wisman PW
    Tijdschr Psychiatr; 2007; 49(5):315-25. PubMed ID: 17492582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: randomized compared with nonrandomized samples.
    Franklin ME; Abramowitz JS; Kozak MJ; Levitt JT; Foa EB
    J Consult Clin Psychol; 2000 Aug; 68(4):594-602. PubMed ID: 10965635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prospective follow-up over a 12 month period of a cohort of 155 patients with obsessive-compulsive disorder: phase III National DRT-TOC Study].
    Hantouche EG; Bouhassira M; Lancrenon S
    Encephale; 2000; 26(6):73-83. PubMed ID: 11217541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychopharmacological treatment of dermatological patients--when simply talking does not help.
    Harth W; Seikowski K; Gieler U; Niemeier V; Hillert A
    J Dtsch Dermatol Ges; 2007 Dec; 5(12):1101-6. PubMed ID: 17877739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severity and duration of obsessive-compulsive complaints. Results of treatment.
    Hoogduin CA; de Haan E; Hoogduin WA; Kraft AR; Rombouts AJ; de Jong PM
    Acta Psychiatr Belg; 1986; 86(3):316-23. PubMed ID: 3751652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Some therapeutic aspects of obsessive-phobic neuroses].
    Sirbu A; Hotico T; Secăreanu A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1975; 20(1):17-21. PubMed ID: 782
    [No Abstract]   [Full Text] [Related]  

  • 27. When pills make sense. Some parents turn too quickly to mood-altering drugs. But often medication is the right choice.
    Sachs A
    Time; 2000 Mar; 155(11):F12. PubMed ID: 11009701
    [No Abstract]   [Full Text] [Related]  

  • 28. Group and individual treatment of obsessive-compulsive disorder using cognitive therapy and exposure plus response prevention: a 2-year follow-up of two randomized trials.
    Whittal ML; Robichaud M; Thordarson DS; McLean PD
    J Consult Clin Psychol; 2008 Dec; 76(6):1003-14. PubMed ID: 19045968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Amenorrhea and behaviour disorders. Clinical case treated by psychotherapeutic methods based on cybberrnetic features of G. Cipollina Mangiameli].
    Cipollina Mangiameli G
    Minerva Med; 1973 Oct; 64(12):3765-9. PubMed ID: 4767740
    [No Abstract]   [Full Text] [Related]  

  • 30. Group behavioral therapy of obsessive-compulsive disorder: seven vs. twelve-week outcomes.
    Himle JA; Rassi S; Haghighatgou H; Krone KP; Nesse RM; Abelson J
    Depress Anxiety; 2001; 13(4):161-5. PubMed ID: 11413562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Validation of a scale for responsibility (Salkovskis Responsibility Scale)].
    Bouvard M; Robbe-Grillet P; Milliery M; Pham S; Amireche S; Fanget F; Guerin J; Cottraux J
    Encephale; 2001; 27(3):229-37. PubMed ID: 11488253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In-patient treatment for resistant obsessive-compulsive disorder.
    Al-Sughayir MA
    Saudi Med J; 2000 Feb; 21(2):193-5. PubMed ID: 11533781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological treatment of obsessive-compulsive disorder.
    Pittenger C; Bloch MH
    Psychiatr Clin North Am; 2014 Sep; 37(3):375-91. PubMed ID: 25150568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful treatment of obsessive-compulsive disorder with ECT.
    Mellman LA; Gorman JM
    Am J Psychiatry; 1984 Apr; 141(4):596-7. PubMed ID: 6703146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of obsessive--compulsive behavior.
    Steketee G
    Curr Psychiatr Ther; 1983; 22():39-51. PubMed ID: 6677440
    [No Abstract]   [Full Text] [Related]  

  • 36. The role of traumatic experiences in the genesis of obsessive-compulsive disorder.
    de Silva P; Marks M
    Behav Res Ther; 1999 Oct; 37(10):941-51. PubMed ID: 10472711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obsessive-compulsive disorder: case study and discussion of treatment.
    Turk J; Marks IM; Horder J
    Br J Gen Pract; 1990 May; 40(334):210-2. PubMed ID: 2114137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.
    Storch EA; Merlo LJ; Bengtson M; Murphy TK; Lewis MH; Yang MC; Jacob ML; Larson M; Hirsh A; Fernandez M; Geffken GR; Goodman WK
    Int Clin Psychopharmacol; 2007 Jul; 22(4):230-7. PubMed ID: 17519647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [I see, I see what you don't see (body dysmorphic syndrome)].
    de Ridder AJ
    Ned Tijdschr Geneeskd; 1997 Feb; 141(5):225-7. PubMed ID: 9064537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of obsessive-compulsive disorder in children and adolescents. A review of the literature.
    Thomsen PH
    Eur Child Adolesc Psychiatry; 1996 Jun; 5(2):55-66. PubMed ID: 8814411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.